Bloom Burton Downgrades Oncolytics Biotech (ONCY) to Hold
Tweet Send to a FriendGet Alerts ONCY Hot Sheet
Price: $2.62 -3.68%
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade ONCY Now!
Bloom Burton downgraded Oncolytics Biotech (NASDAQ: ONCY) from Buy to Hold with a price target of C$4.00.
For an analyst ratings summary and ratings history on Oncolytics Biotech click here. For more ratings news on Oncolytics Biotech click here.
Shares of Oncolytics Biotech closed at $3.38 yesterday, with a 52 week range of $1.60-$5.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Oncolytics Biotech click here. For more ratings news on Oncolytics Biotech click here.
Shares of Oncolytics Biotech closed at $3.38 yesterday, with a 52 week range of $1.60-$5.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- TD Securities Downgrades Nordion Inc (NDZ) to Reduce
- Needham & Company Lifts Numbers on Marvell (MRVL) on Solid Results
Create E-mail Alert Related Categories
Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
